The Micron team recently attended the World Vaccine Congress Europe 2025, where leaders across the vaccine ecosystem gathered to share ideas, explore innovation, and discuss the future of global immunisation.

We’re pleased to share that The Micron Group has partnered with TrialHub, a leading feasibility intelligence platform known for combining real-world data with deep site-level insights.

Micron has successfully completed a Phase 1b clinical trial on behalf of a UK-based biotech company.

Thank you to all the visitors to ESCMID 2025 Booth 11 whose presence helped make it a particularly busy and stimulating meeting to attend.